As age-related diseases escalate, particularly within developed nations, it becomes imperative to focus on mitigating these conditions to improve overall quality of life.
Vascular aging, linked with the rise in long-term disability and mortality among older adults, is intricately tied to organ function decline and age-related disease pathogenesis. Understanding vascular aging's underlying mechanisms holds promise for new therapeutic strategies and clinical diagnostic methods. The integration of AI with thermal hyperspectral imaging presents a promising avenue for groundbreaking advancements in this domain.
Human medical thermography, the result of decades of research, offers a potent tool for visualizing diseases not easily detected or monitored by other methods. Its global application in disease screening, detection, and monitoring is lauded for cost-effectiveness, mobility, non-invasiveness, minimal power requirements, and absence of harmful radiation, meeting the growing demand for safer and more accessible healthcare solutions worldwide.
By targeting vascular aging, amplifAI Health and Healthspan Digital Inc aim to alleviate vascular pathologies contributing to chronic conditions. Their combined expertise will enhance vascular health monitoring and evaluation of therapeutic interventions to mitigate vascular aging's impacts, requiring multidisciplinary and novel approaches.
Dr. Meshari F. Alwashmi, CEO of amplifAI Health, expressed excitement: “We’re thrilled to collaborate with Healthspan, leveraging thermography and AI to extend healthy lifespans for all.”
A key limitation of current medical thermography is human thermographers' limited capacity to observe, analyze, and interpret thermograms. Artificial intelligence (AI) algorithms, particularly computer vision, address this challenge by objectifying findings, reducing inter-observer variability, and enhancing thermographic accuracy and reliability. While computer-aided thermography demands extensive training, it offers potential for faster throughput and centralized processing, leading to improved diagnostic outcomes.
Vascular aging detection lacks universal and user-friendly markers. Peripheral arterial disease, a common manifestation, can be early detected using thermography by analyzing asymmetries and local temperature changes. Handheld smartphone-based thermal infrared imagers offer a creative solution for detecting and monitoring vascular aging.
Dr. Fady Hannah-Shmouni, CEO and Founder of Healthspan Digital Inc., emphasized: “We're excited to collaborate with amplifAI, using innovative imaging to assess vascular aging. Cardiovascular aging and longevity share common mechanisms. Delaying cardiovascular aging increases longevity, and ampifAI’s AI-powered algorithms aid in early detection and surveillance.”
The synergy between amplifAI Health's technological prowess and Healthspan Digital Inc.'s clinical diagnostics expertise heralds a new era in personalized healthcare. This partnership promises advancements in preventing, detecting, and expertly managing age-related vascular conditions. By harnessing amplifAI's AI-powered imaging analysis, Healthspan longevity programs enhance vascular aging and presymptomatic disease detection. With a global expansion vision, both companies aim to bring this offering worldwide, paving the way for prolonged health and a brighter future.
.png)
.png)
.png)
.png)
.png)
